(Reuters) - Catalent Inc said on Monday its Maryland facility would make the drug substance used in the COVID-19 vaccine…
Super UserAugust 31, 2020
In an interview, Peter Meath, J.P. Morgan’s co-head of Healthcare and Life Sciences, Middle Market Banking & Specialized Industries, says…
Super UserAugust 31, 2020
Qiagen has announced plans to launch a new digital test for COVID-19 antibodies that can run multiple samples at once…
Super UserAugust 31, 2020
CAMBRIDGE, Md. and LONDON, Aug. 26, 2020 (GLOBE NEWSWIRE) -- OS Therapies, and late-stage clinical research biotechnology company focused on…
Super UserAugust 31, 2020
GAITHERSBURG, Md., Aug. 26, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that the company’s board of directors…
Super UserAugust 31, 2020
Humans are not the only species facing a potential threat from SARS-CoV-2, according to the results of a study by…
Super UserAugust 31, 2020
The United States aims to invest $765 million over the next 5 years in a dozen scientific centers dedicated to…
Super UserAugust 31, 2020
The US National Institutes of Health (NIH) is one of the largest early stage life sciences investors, and funds over…
Super UserAugust 31, 2020
SOMERSET, N.J. – Aug 24, 2020 — Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development,…
Super UserAugust 31, 2020